Genomic Health (GHDX) Tops Q3 EPS by 2c

Genomic Health (NASDAQ: GHDX) reported Q3 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $69.1 million versus the consensus estimate of $71 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c